←Back to Expert Scholars
Translational Medicine / 转化医学Milestone IO Approvals
Tasuku Honjo
MD, PhD
🏢Kyoto University🌐Japan
Distinguished Professor, Institute for Advanced Study
105
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Tasuku Honjo discovered PD-1 in 1992 and demonstrated its role as an inhibitory immune checkpoint, leading to nivolumab approvals across multiple cancers. He shared the 2018 Nobel Prize in Physiology or Medicine with James Allison. He is distinguished professor at Kyoto University.
Share:
🧪Research Fields 研究领域
PD-1 discovery
Nobel Prize 2018
nivolumab
class switch recombination
immunology pioneer
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Tasuku Honjo 的研究动态
Follow Tasuku Honjo's research updates
留下邮箱，当我们发布与 Tasuku Honjo（Kyoto University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment